These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28243543)

  • 1. Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.
    Vysotskaia VS; Hogan GJ; Gould GM; Wang X; Robertson AD; Haas KR; Theilmann MR; Spurka L; Grauman PV; Lai HH; Jeon D; Haliburton G; Leggett M; Chu CS; Iori K; Maguire JR; Ready K; Evans EA; Kang HP; Haque IS
    PeerJ; 2017; 5():e3046. PubMed ID: 28243543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
    Kang HP; Maguire JR; Chu CS; Haque IS; Lai H; Mar-Heyming R; Ready K; Vysotskaia VS; Evans EA
    PeerJ; 2016; 4():e2162. PubMed ID: 27375968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of next generation sequencing based 35-gene hereditary cancer panel.
    Chan W; Lee M; Yeo ZX; Ying D; Grimaldi KA; Pickering C; Yang MMS; Sundaram SK; Tzang LCH
    Hered Cancer Clin Pract; 2020; 18():9. PubMed ID: 32368312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing of
    Nicolussi A; Belardinilli F; Mahdavian Y; Colicchia V; D'Inzeo S; Petroni M; Zani M; Ferraro S; Valentini V; Ottini L; Giannini G; Capalbo C; Coppa A
    PeerJ; 2019; 7():e6661. PubMed ID: 31065452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.
    Rosenthal SH; Sun W; Zhang K; Liu Y; Nguyen Q; Gerasimova A; Nery C; Cheng L; Castonguay C; Hiller E; Li J; Elzinga C; Wolfson D; Smolgovsky A; Chen R; Buller-Burckle A; Catanese J; Grupe A; Lacbawan F; Owen R
    Biomed Res Int; 2020; 2020():3289023. PubMed ID: 32090079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Next-Generation Sequencing Panel for Syndromic and Nonsyndromic Hearing Loss.
    Butz M; McDonald A; Lundquist PA; Meyer M; Harrington S; Kester S; Stein MI; Mistry NA; Zimmerman Zuckerman E; Niu Z; Schimmenti L; Hasadsri L; Boczek NJ
    J Appl Lab Med; 2020 May; 5(3):467-479. PubMed ID: 32445360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach.
    Bhai P; Levy MA; Rooney K; Carere DA; Reilly J; Kerkhof J; Volodarsky M; Stuart A; Kadour M; Panabaker K; Schenkel LC; Lin H; Ainsworth P; Sadikovic B
    Front Genet; 2021; 12():698595. PubMed ID: 34326862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis.
    Ricci MT; Volorio S; Signoroni S; Mariani P; Mariette F; Sardella D; Pensotti V; Vitellaro M
    Tumori; 2019 Aug; 105(4):338-352. PubMed ID: 31068090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey.
    Bora E; Caglayan AO; Koc A; Cankaya T; Ozkalayci H; Kocabey M; Kemer D; Aksoy S; Alicikus ZA; Akin IB; Durak MG; Gurel D; Yavuzsen T; Sevinc A; Somali I; Gorken I; Balci P; Karaoglu A; Saydam S; Ulgenalp A
    Cancer Genet; 2022 Apr; 262-263():118-133. PubMed ID: 35220195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of copy number variations and point mutations in
    Germani A; Libi F; Maggi S; Stanzani G; Lombardi A; Pellegrini P; Mattei M; De Marchis L; Amanti C; Pizzuti A; Torrisi MR; Piane M
    Oncotarget; 2018 Sep; 9(72):33648-33655. PubMed ID: 30263092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
    Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
    PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification.
    Hogan GJ; Vysotskaia VS; Beauchamp KA; Seisenberger S; Grauman PV; Haas KR; Hong SH; Jeon D; Kash S; Lai HH; Melroy LM; Theilmann MR; Chu CS; Iori K; Maguire JR; Evans EA; Haque IS; Mar-Heyming R; Kang HP; Muzzey D
    Clin Chem; 2018 Jul; 64(7):1063-1073. PubMed ID: 29760218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-laboratory assessment of clinical exome sequencing for detection of hereditary disease variants: 4441 ClinVar variants for clinical genomic test development and validation.
    Zhang K; Yu L; Lin G; Li J
    Clin Chim Acta; 2022 Oct; 535():99-107. PubMed ID: 35985503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.
    Wang SR; Malik S; Tan IB; Chan YS; Hoi Q; Ow JL; He CZ; Ching CE; Poh DYS; Seah HM; Cheung KHT; Perumal D; Devasia AG; Pan L; Ang S; Lee SE; Ten R; Chua C; Tan DSW; Qu JZZ; Bylstra YM; Lim L; Lezhava A; Ng PC; Wong CW; Lim T; Tan P
    J Mol Diagn; 2016 May; 18(3):416-424. PubMed ID: 26970585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
    Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
    Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.